Copyright
©The Author(s) 2022.
World J Clin Pediatr. Jul 9, 2022; 11(4): 341-350
Published online Jul 9, 2022. doi: 10.5409/wjcp.v11.i4.341
Published online Jul 9, 2022. doi: 10.5409/wjcp.v11.i4.341
Figure 1 Distribution of inflammatory bowel diseases in the pediatric population regarding gender.
UC: Ulcerative colitis; CD: Crohn's disease; IBD: Inflammatory bowel disease.
Figure 2 Distribution of the phenotype regarding the behavior of pediatric Crohn's disease patients in the state of Espírito Santo, from August 2012 to July 2014.
B1: Inflammatory; B2: Stricturing; B3: Fistulizing; p: Perianal disease.
Figure 3 Distribution of medicines for pediatric age inflammatory bowel disease patients in the state of Espírito Santo, from August 2012 to July 2014.
SSZ: Sulfasalazine; ASA: Mesalazine; AZA: Azathioprine; MTX: Methotrexate; BIOLOGICAL: Infliximab or adalimumab; UC: Ulcerative colitis; CD: Crohn's disease.
- Citation: Martins AL, Fróes RSB, Zago-Gomes MP. Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil. World J Clin Pediatr 2022; 11(4): 341-350
- URL: https://www.wjgnet.com/2219-2808/full/v11/i4/341.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v11.i4.341